Roles of cell division and gene transcription in the methylation of CpG islands

Molecular and Cellular Biology

Volumn 19, Issue 10, 1999, Pages 6690-6698

  Bender, Christina M ^a   Gonzalgo, Mark L ^a   Gonzales, Felicidad A ^a   Nguyen, Carvell T ^a   Robertson, Keith D ^a   Jones, Peter A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; PROTEIN P16; TRANSCRIPTION FACTOR;

ARTICLE; CELL CYCLE S PHASE; CELL DIVISION; CELL KINETICS; CYTOTOXICITY; DNA METHYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REPRESSOR GENE; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

EUKARYOTA;

EID: 0032827113     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.10.6690     Document Type: Article

References (54)

1. Antequera, F., J. Boyes, and A. Bird. 1990. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62:503-514.
2. Baylin, S. B., J. G. Herman, J. R. Graff, P. M. Vertino, and J.-P. Issa. 1998. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72:141-146.
3. Bender, C. M., M. M. Pao, and P. A. Jones. 1998. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res. 58:95-101.
4. Bender, C. M., J. M. Zingg, and P. A. Jones. 1998. DNA methylation as a target for drug design. Pharmacol. Res. 15:175-187.
5. Bird, A. P. 1987. CpG islands as gene markers in the vertebrate nucleus. Trends Genet. 3:342-347.
6. Brandeis, M., D. Frank, I. Keshet, Z. Siegfried, M. Mendelsohn, A. Nemes, V. Temper, A. Razin, and H. Cedar. 1994. Sp1 elements protect a CpG island from de novo methylation. Nature 371:435-438.
7. Cedar, H., R. Stein, Y. Gruenbaum, T. Naveh-Many, N. Sciaky-Gallili, and A. Razin. 1983. Effect of DNA methylation on gene expression. Cold Spring Harbor Symp. Quant. Biol. 47:605-609.
8. Clark, S. J., J. Harrison, C. L. Paul, and M. Frommer. 1994. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22:2990-2997.
9. Constantinides, P. G., P. A. Jones, and W. Gevers. 1977. Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Nature 267:364-366.
10. Ferguson-Smith, A. C., H. Sasaki, B. M. Cattanach, and M. A. Surani. 1993. Parental origin-specific epigenetic modification of the mouse H19 gene. Nature 362:751-755.
11. Frommer, M., L. E. McDonald, D. S. Millar, C. M. Collis, F. Watt, G. W. Grigg, P. L. Molloy, and C. L. Paul. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89:1827-1831.
12. Gardiner-Garden, M., and M. Frommer. 1987. CpG islands in vertebrate genomes. J. Mol. Biol. 196:261-282.
13. Gonzalez-Zulueta, M., C. M. Bender, A. S. Yang, T. Nguyen, R. W. Beart, J. M. Van Tornout, and P. A. Jones. 1995. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55:4531-4535.
14. Gonzalgo, M. L., T. Hayashida, C. M. Bender, M. M. Pao, Y. C. Tsai, F. A. Gonzales, H. D. Nguyen, T. T. Nguyen, and P. A. Jones. 1998. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res. 58:1245-1252.
15. Gonzalgo, M. L., and P. A. Jones. 1997. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res. 25:2529-2531.
16. Graff, J. R., J. G. Herman, S. Myohanen, S. B. Baylin, and P. M. Vertino. 1997. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J. Biol. Chem. 272:22322-22329.
17. Herman, J. G., J. Jen, A. Merlo, and S. B. Baylin. 1996. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res. 56:722-727.
18. Herman, J. G., F. Latif, Y. Weng, M. I. Lerman, B. Zbar, S. Liu, D. Samid, D. S. Duan, J. R. Gnarra, and W. M. Linehan. 1994. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 91:9700-9704.
19. Herman, J. G., A. Merlo, L. Mao, R. G. Lapidus, J. P. Issa, N. E. Davidson, D. Sidransky, and S. B. Baylin. 1995. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:4525-4530.
20. Hsieh, C.-L. 1994. Dependence of transcriptional repression on CpG methylation density. Mol. Cell. Biol. 14:5487-5494.
21. Hsieh, C.-L. 1997. Stability of patch methylation and its impact in regions of transcriptional initiation and elongation. Mol. Cell. Biol. 17:5897-5904.
22. Issa, J. P., P. M. Vertino, C. D. Boehm, I. F. Newsham, and S. B. Baylin. 1996. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc. Natl. Acad. Sci. USA 93:11757-11762.
23. Jones, P. A. 1996. DNA methylation errors and cancer. Cancer Res. 56:2463-2467.
24. Jones, P. A. 1999. The DNA methylation paradox. Trends Genet. 15:34-37.
25. Jones, P. A., and P. W. Laird. 1999. Cancer epigenetics comes of age. Nat. Genet. 21:163-167.
26. Jones, P. A., and S. M. Taylor. 1980. Cellular differentiation, cytidine analogs and DNA methylation. Cell 20:85-93.
27. Jones, P. A., and S. M. Taylor. 1981. Hemimethylated duplex DNAs prepared from 5-azacytidine-treated cells. Nucleic Acids Res. 9:2933-2947.
28. Jones, P. L., G. J. Veenstra, P. A. Wade, D. Vermaak, S. U. Kass, N. Landsberger, J. Strouboulis, and A. P. Wolffe. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19:187-191.
29. Kass, S. U., J. P. Goddard, and R. L. Adams. 1993. Inactive chromatin spreads from a focus of methylation. Mol. Cell. Biol. 13:7372-7379.
30. Larsen, F., G. Gundersen, R. Lopez, and H. Prydz. 1992. CpG islands as gene markers in the human genome. Genomics 13:1095-1107.
31. Li, E., C. Beard, and R. Jaenisch. 1993. Role for DNA methylation in genomic imprinting. Nature 366:362-365.
32. Li, E., T. H. Bestor, and R. Jaenisch. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915-926.
33. Liang, G., C. E. Salem, M. C. Yu, H. D. Nguyen, F. A. Gonzales, T.-D. T. Nguyen, P. W. Nichols, and P. A. Jones. 1998. DNA methylation differences associated with tumor tissues identified by genome scanning analysis. Genomics 53:260-268.
34. Lock, L. F., D. W. Melton, C. T. Caskey, and G. R. Martin. 1986. Methylation of the mouse hprt gene differs on the active and inactive X chromosomes. Mol. Cell. Biol. 6:914-924.
35. Macleod, D., R. R. Ali, and A. Bird. 1998. An alternative promoter in the mouse major histocompatibility complex class II I-Aβ gene: implications for the origin of CpG islands. Mol. Cell. Biol. 18:4433-4443.
36. Macleod, D., J. Charlton, J. Mullins, and A. P. Bird. 1994. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8:2282-2292.
37. Magewu, A. N., and P. A. Jones. 1994. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol. Cell. Biol. 14:4225-4232.
38. Mao, L., A. Merlo, G. Bedi, G. I. Shapiro, C. D. Edwards, B. J. Rollins, and D. Sidransky. 1995. A novel p16INK4A transcript. Cancer Res. 55:2995-2997.
39. Merlo, A., J. G. Herman, L. Mao, D. J. Lee, E. Gabrielson, P. C. Burger, S. B. Baylin, and D. Sidransky. 1995. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1:686-692.
40. Michalowsky, L. A., and P. A. Jones. 1987. Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance. Mol. Cell. Biol. 7:3076-3083.
41. Mohandas, T., R. S. Sparkes, and L. J. Shapiro. 1981. Reactivation of an inactive X human chromosome: evidence for X inactivation by DNA methylation. Science 211:393-396.
42. Nan, X., H. H. Ng, C. A. Johnson, C. D. Laherty, B. M. Turner, R. N. Eisenman, and A. Bird. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389.
43. Okano, M., S. Xie, and E. Li. 1998. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet. 19: 219-220.
44. Ottaviano, Y. L., J. P. Issa, F. F. Parl, H. S. Smith, S. B. Baylin, and N. E. Davidson. 1994. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 54:2552-2555.
45. Razin, A. 1984. DNA methylation patterns: formation and biological functions, p. 127-146. In A. Razin, H. Cedar, and A. D. Riggs (ed.), DNA methylation: biochemistry and biological significance. Springer-Verlag Press, New York, N.Y.
46. Riggs, A. D., and G. P. Pfeifer. 1992. X-chromosome inactivation and cell memory. Trends Genet. 8:169-174.
47. Sakai, T., J. Toguchida, N. Ohtani, D. W. Vandell, J. M. Rapaport, and T. P. Dryja. 1991. Allele-specific hypermethylation of the retinoblastoma tumorsuppressor gene. Am. J. Hum. Genet. 48:880-888.
48. Salem, C. E., I. D. C. Markl, C. M. Bender, P. A. Jones, and G. Liang. PAX6 expression and methylation in human tumor cells. Submitted for publication.
49. Szyf, M., V. Bozovic, and G. Tanigawa. 1991. Growth regulation of mouse DNA methyltransferase gene expression. J. Biol. Chem. 266:10027-10030.
50. Tate, P. H., and A. P. Bird. 1993. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. 3:226-231.
51. Taylor, S. M., and P. A. Jones. 1982. Mechanism of action of eukaryotic DNA methyltransferase. Use of 5-azacytosine-containing DNA. J. Mol. Biol. 162:679-692.
52. Wutz, A., O. W. Smrzka, N. Schweifer, K. Schellander, E. F. Wagner, and D. P. Barlow. 1997. Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 389:745-749.
53. Zhang, Y., T. Shields, T. Crenshaw, Y. Hao, T. Moulton, and B. Tycko. 1993. Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am. J. Hum. Genet. 53:113-124.
54. Zion, M., D. Ben-Yehuda, A. Avraham, O. Cohen, M. Wetzler, D. Melloul, and Y. Ben-Neriah. 1994. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 91:10722-10726.